ZEO ScientifiX, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of degenerative diseases. Its product is Zofin, which is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Davie, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
38
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Zeo ScientifiX Inc. market cap is $6.27M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zeo ScientifiX Inc. 52 week high is $2.99 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zeo ScientifiX Inc. 52 week low is $0.7528 as of November 18, 2026.
Zeo ScientifiX Inc. stock price today is $0.80.
Zeo ScientifiX Inc. stock price yesterday was $0.7964.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Zeo ScientifiX Inc.'s P/E ratio is -1.37.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Zeo ScientifiX Inc. P/B ratio is 8.7499.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Zeo ScientifiX Inc. 50-day moving average is $1.16.